2008 Steering Committee
• Susan Alpert, SVP, Chief Quality and
Regulatory Officer, Medtronic
• Peyton Anderson, CEO, Affinergy
• Fred J. Dotzler, Managing Director, De Novo Ventures
• Mike Dunn, VP Business Development
and Chief Business Officer,
Monogram Biosciences
• Matthew M. Gardner, President and
Chief Executive Officer, BayBio
• Scott Gottlieb, MD,
American Enterprise Institute
• Ogan Gurel, MD, Chairman, Aesis Group
• Steve Halasey, Editor in Chief, MX
• Dale Hagemeyer, Research VP
Manufacturing Section of Industry
Advisory Services, Gartner
• Susan Herschenson, PhD,
Vice President, Pharmaceutical and
Device Development, Genentech, Inc.
• Arthur S. Hsieh, J.D., Ph.D. Chief Patent Counsel Hansen Medical, Inc.
• Lisa Perrin, Group Publisher,
Canon Communications
• Glenn Pierce, MD, PhD, Scientific Head,
U.S. Research Center, Vice President
Applied Research Bayer HealthCare
• Rhall E. Pope, PhD, VP, R&D,
Smiths Medical MD
• Patrick Terry, Cofounder, Director of
Consumer Advocacy and Government
Affairs, Genomic Health
• Josiah N. Wilcox, PhD, Vice President
of Science and Technology,
Medtronic Cardiovascular
2008 Conference Speaking Faculty
• Mike Samoszuk, Chief Medical Officer, Roche Diagnostics
• Frank Torti, Principal Deputy Commissioner and Chief Scientist, FDA
• Ken Andrews, CEO & President, Histogenics
• Sanjay S. Bagade, Partner, Levine Bagade Han LLP
• Amir Belson, MD, Co-Founder & Chief Technical Office, Neoguide Systems
• Tim Bertram, SVP Technology & Science, Tengion
• Leslie Bottorff, General Partner, Medical Technology, ONSET Ventures
• Stephen Dahms, Ph.D., President/CEO, Alfred E. Mann Foundation for Biomedical Engineering
• Mike Dunn, Vice President Business Development and Chief Business Officer, Monogram Biosciences
• Matthew Gardner, President & CEO, BayBIO
• Pierre Gobin, MD Prof. Radiology in Neurology, Attending Radiologist, Weill Cornell Medical College
• Dennis Goldberg, President & CEO, Transport Pharmaceuticals
• Ogan Gurel, MD, Aesis Group
• Geoffrey Gurtner, MD, FAC Department of Surgery, Division of Plastic Surgery and Reconstruction, Stanford University School of Medicine
• Steve Halasey, Editor in Chief MX, Strategies
• Suzanne Kiani, MS, Senior Scientist; Chemistry, Manufacturing, and Controls Regulatory Affairs; Genentech
• John Lopez, MD, Director, Cardiac Catheterization Laboratory, University of Chicago Hospitals
• Gokhan Mutlu, MD, Assistant Professor, Division of Pulmonary & Critical Care, Northwestern University
• George Poste, DVM, PhD, DSc, Director, BioDesign Institute, and Chief Scientist, Complex Adaptive Systems Initiative, Arizona State University
• Nancy Reaven, President, Strategic Health Resources
• William Revelos, General Counsel, Zeltiq Aesthetics
• M. Bret Schneider, MD, Consulting Assistant Professor, Department of Psychiatry, Department of Neurosurgery, Stanford University School of Medicine
• Eduardo Schur, Managing Director, Navigant Consulting
• Nandini Tandon, Managing Director, Lumira Capital
• Bradley Merrill, Thompson Epstein, Becker & Green
• Josiah N. Wilcox, Ph.D., VP Science & Technology, Medtronic
• Deborah Schenberger, Ph.D, Analyst, Nerac
• John Barlow Weiner, Associate Chief Counsel, Office of the Chief Counsel, Food and Drug Administration
• John Varaklis, Head of Operations and Innovation for Translational Medicine at Novartis